Evidence map›Paper›PMID 31049241›Full record

ArticleCase reports in surgery2019

Efficacy of Neoadjuvant Chemotherapy with Capecitabine plus Oxaliplatin in the Treatment of Locally Advanced Sigmoid Colon Cancer Invading the Urinary Bladder: A Report of Three Cases.

Tsutomu Takenami, Shingo Tsujinaka, Jun Takahashi, Sawako Tamaki, Ryo Maemoto, Rintaro Fukuda, Hideki Ishikawa, Nao Kakizawa, Fumi Hasegawa, Rina Kikugawa and 4 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Case reports in surgery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Tsutomu TakenamiDepartment of Surgery, Saitama Medical Center, Jichi Medical University, Japan.
Shingo TsujinakaDepartment of Surgery, Saitama Medical Center, Jichi Medical University, Japan.ORCID 0000-0002-8554-3869
Jun TakahashiDepartment of Surgery, Saitama Medical Center, Jichi Medical University, Japan.
Sawako TamakiDepartment of Surgery, Saitama Medical Center, Jichi Medical University, Japan.
Ryo MaemotoDepartment of Surgery, Saitama Medical Center, Jichi Medical University, Japan.
Rintaro FukudaDepartment of Surgery, Saitama Medical Center, Jichi Medical University, Japan.
Hideki IshikawaDepartment of Surgery, Saitama Medical Center, Jichi Medical University, Japan.
Nao KakizawaDepartment of Surgery, Saitama Medical Center, Jichi Medical University, Japan.
Fumi HasegawaDepartment of Surgery, Saitama Medical Center, Jichi Medical University, Japan.
Rina KikugawaDepartment of Surgery, Saitama Medical Center, Jichi Medical University, Japan.
Yasuyuki MiyakuraDepartment of Surgery, Saitama Medical Center, Jichi Medical University, Japan.
Koichi SuzukiDepartment of Surgery, Saitama Medical Center, Jichi Medical University, Japan.
Akira TanakaDepartment of Pathology, Saitama Medical Center, Jichi Medical University, Japan.
Toshiki RikiyamaDepartment of Surgery, Saitama Medical Center, Jichi Medical University, Japan.
Jichi Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionWe herein present three cases of locally advanced colon cancer (LACC) invading the urinary bladder, in whom combined neoadjuvant chemotherapy with surgical intervention was effective in disease control and preserving urinary function. CASE PRESENTATION: Before neoadjuvant chemotherapy, all three cases underwent loop transverse colostomy for symptomatic colonic obstruction. Case 1: after 6 courses of capecitabine plus oxaliplatin (CAPOX), we performed sigmoid colectomy and partial resection of the bladder. The histological examination revealed pathological complete response (pCR). The final diagnosis was ypStage 0 (ypT0ypN0M0). Case 2: after 13 courses of CAPOX plus bevacizumab, we performed Hartmann's operation with partial resection of the bladder. The histological examination revealed pCR. The final diagnosis was ypStage 0 (ypT0ypN0M0). Case 3: after 6 courses of chemotherapy with CAPOX plus bevacizumab, we performed sigmoid colectomy and partial resection of the bladder. The pathological response was grade 1a according to the Japanese Classification of Colorectal Carcinoma. The final diagnosis was ypStage IIC (ypT4bypN0M0). All three cases underwent capecitabine-based adjuvant chemotherapy after radical surgery and patients are alive without recurrence.

conclusionNeoadjuvant chemotherapy with CAPOX with or without bevacizumab followed by radical surgery could be an effective treatment option for LACC invading the urinary bladder.

Identifiers

PMID31049241
PMCPMC6458894
OpenAlexW2924180948

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.